ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Markets/EquitiesArticle

Applied Nutrition shares surge 5% after FY26 beat, FY27 guidance raised

UK vitamin and sports-nutrition firm posts FY26 revenue of £160m and adjusted EBITDA of £43.3m, beating consensus. FY27 outlook lifted as North American expansion accelerates.

PA
Priya Anand · Equities & Earnings Desk · 26 Aug 2026 · 17:24 · 1 min read
Share
Applied Nutrition shares surge 5% after FY26 beat, FY27 guidance raised

Applied Nutrition’s shares rose 5.15% to 338.05 pence on Wednesday after the company reported FY26 revenue of approximately £160 million, a 50% year-over-year increase that exceeded S&P Global Consensus estimates. Adjusted EBITDA for the year reached about £43.3 million, up roughly 40% and also ahead of consensus.

The company raised its FY27 outlook, signaling stronger growth momentum following a stronger-than-expected finish to FY26. Shares remain near their 52-week high of 355 pence, while the FTSE 250 advanced 0.6%.

Applied Nutrition is expanding its North American manufacturing footprint, including a June agreement to acquire the assets of Nutrablend Group. The deal provides a U.S. production facility and additional capacity, alongside a new collaboration to produce sports-nutrition products under the SOUR PATCH KIDS and SWEDISH FISH brands. The company also highlighted ongoing partnerships with major retailers and distributors, including Holland & Barrett, and new listings with U.S. retailers.

The FY26 performance reflects the benefits of Applied Nutrition’s strategic expansion and growing market penetration in both domestic and international markets.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
ADVERTISEMENT